今日观察！A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

Shanghai, China - June 17, 2024 - A recent surge in investor sentiment towards growth stocks, particularly in the healthcare and technology sectors, has been dubbed the "Kete Valuation" phenomenon, named after the Chinese pharmaceutical company C-Bridge (6160.HK). This trend is reminiscent of the "CATL Valuation" rally that occurred in 2021, driven by the strong performance of Contemporary Amperex Technology Co., Ltd. (300015.SZ).

The "Kete Valuation" is characterized by a sharp increase in the share prices of companies with promising growth prospects, often defying broader market trends. This is evident in the recent performance of 50 stocks identified by analysts as having significant growth potential. These stocks, spanning various industries including healthcare, technology, and consumer goods, have exhibited remarkable resilience amidst recent market volatility.

Factors Driving the "Kete Valuation"

Several factors are contributing to the "Kete Valuation" trend. Firstly, investors are increasingly seeking out companies that can deliver sustainable growth, particularly in the face of global economic uncertainties. Secondly, the easing of monetary policy in major economies is providing a supportive backdrop for riskier assets like growth stocks. Additionally, advancements in technology and innovation are creating new opportunities for companies in various sectors, fueling investor optimism.

Key Beneficiaries of the "Kete Valuation"

Among the 50 stocks identified as potential beneficiaries of the "Kete Valuation," C-Bridge (6160.HK) stands out as a frontrunner. The company's innovative cancer therapies and strong pipeline of new drugs have attracted significant investor interest. Other notable stocks include:

• Ascletis Pharma (1672.HK): A clinical-stage biopharmaceutical company developing novel therapies for cancer and viral diseases.

• Aier Eye Hospital Group (300015.SZ): A leading provider of comprehensive eye care services in China.

• Xiaomi Corporation (1810.HK): A global technology company known for its smartphones, smart home devices, and internet services.

Investment Implications

The "Kete Valuation" presents an opportunity for investors to capitalize on the growth potential of select companies. However, careful due diligence is crucial, as not all growth stocks are created equal. Investors should thoroughly evaluate a company's financial health, competitive landscape, and long-term growth prospects before making investment decisions.

The "Kete Valuation" highlights the evolving dynamics of the Chinese stock market, where investors are increasingly discerning and seeking out companies with genuine growth potential. This trend is likely to continue as China's economy transitions towards a more innovation-driven and knowledge-based model.

百川智能CEO王小川：AI安全尚无近期威胁 现阶段应聚焦能力提升

北京讯（记者 张楠楠）6月14日，在北京智源大会上，百川智能CEO王小川发表演讲，谈及了AI安全问题。他表示，**现阶段的AI能力还很弱，**远达不到能够颠覆人类的程度，因此近期不存在安全问题。王小川认为，AI安全问题的关键在于能力，只有当AI能力发展到足以对人类社会造成重大影响时，安全问题才会真正凸显。

王小川指出，当前的AI主要应用于一些相对简单的场景，例如图像识别、语音识别、自然语言处理等，这些AI系统还无法进行复杂自主的思考和决策，因此很难对人类社会构成威胁。

**王小川强调，**与其担忧AI安全问题，不如集中精力提升AI能力。**他呼吁业界共同努力，**推动AI技术发展，让AI能够更好地服务于人类社会。

**除了王小川之外，**其他参会的嘉宾也对AI安全问题发表了各自的看法。**智谱AI CEO张鹏认为，**AI安全是一项长期挑战，**需要从技术、伦理、法律等多个方面入手进行综合治理。**月之暗面CEO杨植麟则表示，AI安全问题的核心是价值观问题，需要建立一套符合人类价值观的AI发展体系。

AI安全一直是备受关注的话题。**近年来，**随着AI技术的快速发展，**一些关于AI可能被滥用的担忧也不断涌现。**专家们呼吁，**业界应高度重视AI安全问题，**共同努力，确保AI技术能够安全可靠地应用于人类社会。